Danimer Scientific Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

Equity (Tables)

6 Months Ended

Jun. 30, 2021

Stockholders' Equity Note [Abstract]

The following table summarizes the common stock activity for the three and six months ended June 30, 2021 and 2020:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2021		2020 (1)		2021		2020 (1)
Common stock:
Balance, beginning of period		85,339,145		29,005,309		84,535,640		25,371,186
Issuance of common stock		12,392,934		-		13,196,439		3,634,123
Balance, end of period		97,732,079		29,005,309		97,732,079		29,005,309

(1) Retroactively restated for Business Combination

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The following instruments were excluded from the calculation of diluted shares outstanding because the effect of including them would have been anti-dilutive.


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Employee stock options		37,500		11,108,755		10,682,969		11,108,755
Public Warrants		-		-		-		-
Private Warrants		-		-		3,915,863		-
Restricted shares		-		-		3,035,676		-
Legacy Danimer options		-		1,906,540		125,490		1,906,540
Legacy Danimer warrants		-		506,611		-		506,611
Total excluded instruments		37,500		13,521,906		17,759,998		13,521,906